What question did this study set out to answer?

To evaluate capillary β-hydroxybutyrate (β-OHB) levels in diagnosing diabetic ketoacidosis (DKA).

A review of capillary β‐hydroxybutyrate cut‐off levels for the exclusion and identification of diabetic ketoacidosis

View Full Paper

Ask AI

Bookmark

To evaluate capillary β-hydroxybutyrate (β-OHB) levels in diagnosing diabetic ketoacidosis (DKA).
Reviewed existing literature on β-OHB levels relevant to DKA diagnosis.
Assessed cut-off levels for excluding and identifying DKA.
Capillary β-OHB threshold of <1.5 mmol/L may exclude DKA.
A level >3.0 mmol/L showed high sensitivity and specificity for DKA detection.

No takes yet. Share an insight, caveat, or question.

Review identifies capillary β-hydroxybutyrate cut-off levels for confirming or excluding diabetic ketoacidosis, suggesting clinical implications.

Tran et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Review identifies capillary β-hydroxybutyrate cut-off levels for confirming or excluding diabetic ketoacidosis, suggesting clinical implications.